PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically
Nature Medicine2015Vol. 22(1), pp. 37–45
Citations Over TimeTop 10% of 2015 papers
Audrey S. Dickey, Victor V. Pineda, Taiji Tsunemi, Patrick P. Liu, Helen C. Miranda, Stephen K. Gilmore-Hall, Nicole Lomas, Kunal R. Sampat, Anne Buttgereit, Mark-Joseph Manalang Torres, April L. Flores, Martin Arreola Villanueva, Nicolas Arbez, Sergey Akimov, Terry Gaasterland, Eduardo R. Lazarowski, Christopher A. Ross, G Yeo, Bryce L. Sopher, Gavin Magnuson, Anthony B. Pinkerton, Eliezer Masliah, Albert R. La Spada
Related Papers
- → Huntingtin–protein interactions and the pathogenesis of Huntington's disease(2004)540 cited
- → Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion(1997)522 cited
- → Huntington's disease: from pathology and genetics to potential therapies(2008)406 cited
- → Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine Proteins(1998)278 cited
- Huntingtin and Huntington’s Disease(2006)